Created in 2010 (United States), CYFANTIR own 18 sister brands and 2214 competing brands. The CYFANTIR brand is owned by Vertex Pharma, a company listed in New York. CYFANTIR belongs to the Biotechnology business sector.
Investment simulator :
Portfolio valuation
Vertex Pharma
(CYFANTIR)
over 5 years*
USD 932.47